Literature DB >> 11960819

Development of new treatments for congenital nystagmus.

Louis F Dell'Osso1.   

Abstract

The use of ocular motor data as the basis for the development of both nonsurgical and surgical therapies for congenital nystagmus (CN) has been underway since the mid-1960s. This paper presents three nonsurgical therapies (composite prisms, soft contact lenses, and afferent stimulation) and a new surgical therapy (four-muscle tenotomy) hypothesized from analysis of ocular motor data. The expanded nystagmus acuity function test was developed to both predict and measure the effectiveness of CN therapies and for intersubject comparisons. Base-out prisms may be used to damp CN during distance fixation in patients whose CN damps during near fixation and who are binocular (i.e., they have no strabismus). Soft contact lenses may be used in those whose CN damps with afferent stimulation of the ophthalmic division of the trigeminal nerve. Cutaneous afferent stimulation (rubbing, vibration, or electricity) of the forehead or neck damps CN in some individuals. Finally, as first demonstrated in an achiasmic Belgian sheepdog and later in humans, tenotomy of the four horizontal rectus muscles and reattachment at their original sites may also damp CN. Taken together, these findings suggest the existence of one or more proprioceptive feedback loops acting to change the small-signal gain of the extraocular plant. Four-muscle tenotomy provides a needed therapeutic option for the many individuals with CN for whom other surgical therapies are contraindicated. Tenotomy may also prove useful in see-saw nystagmus (it abolished it in the aforementioned canine) or other types of nystagmus; further studies of the latter are required.

Entities:  

Mesh:

Year:  2002        PMID: 11960819     DOI: 10.1111/j.1749-6632.2002.tb02834.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  Medical treatment of nystagmus and its visual consequences.

Authors:  John S Stahl; Gordon T Plant; R John Leigh
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

Review 2.  [Nystagmus. Clinical characteristics and therapeutic options].

Authors:  B Käsmann-Kellner
Journal:  Ophthalmologe       Date:  2016-03       Impact factor: 1.059

3.  Current Treatment of Nystagmus.

Authors:  Janet C Rucker
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

4.  Albinism: particular attention to the ocular motor system.

Authors:  Richard W Hertle
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep

5.  Genotype-Phenotype Analysis and Mutation Spectrum in a Cohort of Chinese Patients With Congenital Nystagmus.

Authors:  Xiao-Fang Wang; Hui Chen; Peng-Juan Huang; Zhuo-Kun Feng; Zi-Qi Hua; Xiang Feng; Fang Han; Xiao-Tao Xu; Ren-Juan Shen; Yang Li; Zi-Bing Jin; Huan-Yun Yu
Journal:  Front Cell Dev Biol       Date:  2021-02-19

6.  Eye movements elevate crowding in idiopathic infantile nystagmus syndrome.

Authors:  Vijay K Tailor; Maria Theodorou; Annegret H Dahlmann-Noor; Tessa M Dekker; John A Greenwood
Journal:  J Vis       Date:  2021-12-01       Impact factor: 2.004

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.